TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 25 filers reported holding TSCAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $9 | -10.0% | 4,147 | -33.7% | 0.00% | – |
Q4 2022 | $10 | -99.9% | 6,255 | +3.5% | 0.00% | – |
Q3 2022 | $18,000 | -35.7% | 6,043 | -33.1% | 0.00% | -100.0% |
Q2 2022 | $28,000 | +27.3% | 9,027 | +14.4% | 0.00% | – |
Q1 2022 | $22,000 | +29.4% | 7,889 | +109.3% | 0.00% | – |
Q4 2021 | $17,000 | – | 3,770 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DC Funds, LP | 630,000 | $1,612,800 | 33.20% |
Lynx1 Capital Management LP | 5,224,600 | $13,374,976 | 8.85% |
EcoR1 Capital, LLC | 5,000,000 | $12,800,000 | 0.43% |
Deer Management Co. LLC | 1,245,505 | $3,188,493 | 0.39% |
Simplify Asset Management Inc. | 1,046,916 | $2,680,105 | 0.31% |
BVF INC/IL | 2,989,474 | $7,653,053 | 0.21% |
Alphabet Inc. | 1,077,080 | $2,757,324 | 0.18% |
DC Investments Management, LLC | 35,563 | $91,041 | 0.11% |
Baker Brothers Advisors | 2,784,792 | $7,129,068 | 0.04% |
Privium Fund Management (UK) Ltd | 15,825 | $41,462 | 0.03% |